Compare PBYI & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBYI | VMD |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 280.4M |
| IPO Year | N/A | N/A |
| Metric | PBYI | VMD |
|---|---|---|
| Price | $5.27 | $6.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 637.1K | 133.9K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | 35.92 |
| EPS | ★ 0.74 | 0.34 |
| Revenue | $211,995,000.00 | ★ $254,794,000.00 |
| Revenue This Year | N/A | $20.05 |
| Revenue Next Year | N/A | $17.44 |
| P/E Ratio | ★ $7.10 | $19.88 |
| Revenue Growth | N/A | ★ 18.89 |
| 52 Week Low | $2.58 | $5.93 |
| 52 Week High | $6.12 | $8.96 |
| Indicator | PBYI | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 52.45 |
| Support Level | $4.84 | $6.60 |
| Resistance Level | $5.11 | $6.98 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 91.59 | 61.49 |
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.